Bank of America buys 427,275 shares in SIGA Technologies stock

Published on 10/02/2026 at 14:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Bank of America disclosed 427,275 SIGA shares from the second quarter. For SIGA Technologies stock, Q2 revenue was USD 41.0 million.

SIGA, US8269171067, Illustration mit AI erstellt.

Bank of America disclosed a second-quarter purchase of 427,275 SIGA shares valued at USD 1.6 million, as MarketBeat reported on October 2, 2026. The filing puts the institutional purchase alongside SIGA Technologies' volatile government procurement cycle.

What the stake means

SIGA's second-quarter revenue was USD 41.0 million, down from USD 81.1 million in the same period of 2025, according to The Globe and Mail. The comparison highlights how delivery timing can materially change the companys quarterly profile.

Net income reached USD 12.5 million in the second quarter of 2026, versus USD 35.5 million a year earlier, while diluted earnings per share fell to USD 0.17 from USD 0.49. The figures show that SIGA remained profitable even as revenue and profit contracted year over year.

Cash supports the transition

Cash and cash equivalents totaled USD 117.6 million on June 30, 2026, compared with USD 155.0 million at the end of 2025, according to The Globe and Mail. The balance sheet also carried zero debt, giving the company financial capacity while it pursues additional government and international orders.

The company completed the final product order under its 19C contract during the second quarter. Management is pursuing a successor multiyear procurement agreement, while an international customer delivery is targeted for March 2027 and a post-exposure prophylaxis FDA submission is targeted for the first half of 2027, according to the transcript.

Next report date is set

Investing.com lists SIGA on Nasdaq under ticker SIGA and names November 5, 2026, as the next earnings date. The same page shows a USD 2.83 to USD 9.25 52-week range and a USD 241.1 million market capitalization, placing institutional buying in the context of a small-cap healthcare security company.